Optic neuropathy caused by naso-orbital mass in chronic intranasal cocaine abuse.

J Neuroophthalmol

Hamilton Eye Institute, University of Tennessee, Health Sciences Center, Memphis, Tennessee 38163, USA.

Published: March 2009

A 48-year-old woman with a history of chronic intranasal cocaine abuse presented with unilateral proptosis associated with severe visual loss from optic neuropathy in the right eye. Imaging showed extensive bone and soft tissue destruction in the paranasal region and an orbital mass. Initial biopsies suggested a low-grade neoplasm. The correct diagnosis was established only on repeat biopsy, which revealed marked pleomorphism and nonspecific chronic inflammation with irregular collagen bundles containing thick-walled blood vessels. This case emphasizes that intranasal cocaine abuse may clinically, radiographically, and histopathologically mimic a neoplasm or a necrotizing vasculitis.

Download full-text PDF

Source
http://dx.doi.org/10.1097/WNO.0b013e3181989adbDOI Listing

Publication Analysis

Top Keywords

intranasal cocaine
12
cocaine abuse
12
optic neuropathy
8
chronic intranasal
8
neuropathy caused
4
caused naso-orbital
4
naso-orbital mass
4
mass chronic
4
abuse 48-year-old
4
48-year-old woman
4

Similar Publications

This comprehensive review examines the ocular vascular complications of cocaine use, focusing on its effects on retinal vasculature and inflammation. A rare case of bilateral frosted branch angiitis (FBA) in a 48-year-old man with a history of intranasal cocaine abuse is presented as an illustrative example to stimulate discussion. The case highlights severe retinal ischemia and vascular sheathing, with no identifiable infectious or autoimmune cause, ultimately complicated by systemic vascular events.

View Article and Find Full Text PDF
Article Synopsis
  • Oxytocin is being studied as a potential treatment for psychostimulant use disorders, particularly its effects on dopamine signaling in the striatum, a brain region linked to natural rewards.
  • In a study involving male rhesus macaques, oxytocin was administered both intranasally and intravenously before administering methylphenidate, a stimulant similar to cocaine, and the impacts on dopamine release were monitored.
  • Results showed that oxytocin significantly decreased dopamine release in the dorsal striatum when stimulated by methylphenidate, suggesting oxytocin may be useful in treating addictions to psychostimulants.
View Article and Find Full Text PDF

Oxytocin moderates fMRI connectivity and response to implicit threat processing in cocaine use disorder.

Psychoneuroendocrinology

January 2025

Department of Neuroscience, Medical University of South Carolina, 135 Cannon Street, Charleston, SC 29425, USA. Electronic address:

Article Synopsis
  • * The study involved participants with and without CUD receiving either OXT or a placebo and then completing a fMRI task to observe brain reactions to emotional facial cues.
  • * Results showed that OXT reduced certain brain activations linked to fear and anger responses and positively altered brain connectivity related to emotion regulation specifically in those with CUD, suggesting potential benefits of OXT but highlighting the need for further research on its clinical relevance.
View Article and Find Full Text PDF

Context.—: Manifestations of immunoglobulin G4-related disease (IgG4-RD) occur in several organ systems and anatomic locations, including the nasal cavity and paranasal sinuses. Other processes affecting the sinonasal tract, such as chronic rhinosinusitis, aspirin-exacerbated respiratory disease, and nasal polyposis, also involve IgG4.

View Article and Find Full Text PDF

Detection of cocaine 24 h after administration before nasotracheal intubation.

Acta Anaesthesiol Scand

October 2024

Department of Anaesthesia, Centre of Head and Orthopaedics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Article Synopsis
  • Cocaine can be used as a nasal spray to relieve congestion before nasotracheal intubation, but there are legal risks if it is detected in patients during driving after surgery.
  • A study evaluated benzoylecgonine levels in saliva and cocaine levels in blood to see if they exceeded legal limits 1 and 24 hours post-surgery.
  • Results showed that 13% of patients had detectable benzoylecgonine in saliva and 3% had detectable cocaine in blood 24 hours after administration, highlighting the need for patients to be cautioned against driving for at least a day post-surgery.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!